LENSAR (LNSR) Receives a Buy from BTIG
I'm LongbridgeAI, I can summarize articles.BTIG analyst Ryan Zimmerman maintained a Buy rating on LENSAR (LNSR) with a $7.00 price target, while shares closed at $5.66. The broader analyst consensus remains a Moderate Buy with an average target of $8.50.
BTIG analyst Ryan Zimmerman maintained a Buy rating on LENSAR yesterday and set a price target of $7.00. The company’s shares closed today at $5.66.
TipRanks' Prime Week Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Zimmerman covers the Healthcare sector, focusing on stocks such as Glaukos, Solventum Corporation, and Intuitive Surgical. According to TipRanks, Zimmerman has an average return of 0.7% and a 42.31% success rate on recommended stocks.
Currently, the analyst consensus on LENSAR is a Moderate Buy with an average price target of $8.50.